Personalized, Gene-Based Risk Testing For Lung Cancer Gives New Tool To Help Smokers Quit

Tue, 29 Sep 2009 18:10:00 0500

PHILADELPHIA-(Business Wire)-September 29, 2009 - Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

Clinical Data, Inc. to Present at the JMP Securities Healthcare Focus Conference

Tue, 29 Sep 2009 17:25:00 0500

NEWTON, Mass.-(Business Wire)-September 29, 2009 - Clinical Data, Inc. (NASDAQ: CLDA), today announced...

Cubist Pharmaceuticals Announces Enhanced Careers Section of Corporate Website

Tue, 29 Sep 2009 16:15:00 0500

LEXINGTON, Mass.-(Business Wire)-September 29, 2009 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) is pleased to announce the re-launch of its corporate website and the introduction of the newly created

RegeneRx’s Tβ4 Significantly Improves Functional Recovery in Multiple Sclerosis Animal Model

Tue, 29 Sep 2009 15:42:00 0500

BETHESDA, Md.-(Business Wire)-September 29, 2009 - REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers at the Henry Ford Health System in Detroit, Michigan, demonstrated for the first time that Tβ4 treatment of EAE (experimental autoimmune...

Court Rules in Favor of Bard in Class Action Lawsuit

Tue, 29 Sep 2009 15:30:00 0500

MURRAY HILL, N.J.-(Business Wire)-September 29, 2009 - C. R. Bard, Inc. (NYSE: BCR) today announced that the U.S. District Court, Eastern District of Missouri, has granted Bard's summary judgment motion and dismissed with prejudice all counts in the previously-disclosed class action lawsuit...

LifeCycle Pharma Announces Positive Results from a 12 Month Extension Phase of the Phase 2 Clinical Study of LCP-Tacro™ Once Daily in Stable Liver Transplant Patients

Tue, 29 Sep 2009 15:20:00 0500

HØRSHOLM, Denmark-(Business Wire)-September 29, 2009 - LifeCycle Pharma A/S (CSE:LCP) today announced positive results from a completed 12 month extension phase of the Phase 2 clinical study of LCP-Tacro tablets in stable liver transplant patients. LCP-Tacro is a once daily immunosuppression...

PolyMedix Initiates Dosing in Phase 1B Clinical Study of Novel Anticoagulant Antagonist Compound

Tue, 29 Sep 2009 15:17:00 0500

RADNOR, Pa.-(Business Wire)-September 29, 2009 - PolyMedix, Inc. (OTC BB: PYMX, APCER Pharma Solutions, Inc.’s

SafeStitch Medical, Inc. Appoints Dr. Chao Chen to Board of Directors

Tue, 29 Sep 2009 14:34:00 0500

MIAMI-(Business Wire)-September 29, 2009 - SafeStitch Medical, Inc. (OTCBB: SFES) announced today that, on September 24, 2009, the Company’s Board of Directors appointed Chao C. Chen, Ph.D. to fill the vacant seat on the Company’s Board.

“We are very excited to welcome...

Impulse Monitoring to Provide Neuromonitoring Support to Vanderbilt University Medical Center

Tue, 29 Sep 2009 14:32:00 0500

COLUMBIA, Md.-(Business Wire)-September 29, 2009 - Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiological monitoring (IONM) services to hospitals, today announced that it has signed an agreement with the Vanderbilt University Medical Center (VUMC), Nashville...

Metabolomics Used to Discover Biomarkers for Periodontal Disease

Tue, 29 Sep 2009 14:00:00 0500

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 29, 2009 - Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying biomarkers for periodontitis and gingivitis. Co-authored by scientists at...

Luminex Corporation Hosts Seventh Annual Planet xMAP Europe

Tue, 29 Sep 2009 14:00:00 0500

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it will host Planet xMAP Europe 2009, its annual European multiplexing technology symposium, October 7-8, 2009, at Beurs van Berlage in Amsterdam. The program for...

Bio Japan 2009: The Biggest Biotechnology Event in Japan.

Tue, 29 Sep 2009 13:07:00 0500

YOKOHAMA, Japan-(Business Wire)-September 29, 2009 - We would like to thank you sincerely for your understanding and ongoing cooperation for BioJapn.

With your wholehearted support, BioJapan has been progressing successfully in both its contents and scale every year...

Pluristem Therapeutics Has Been Selected to Present at The Israeli Presidential Conference 2009: Facing Tomorrow, Based on the Company’s Proprietary Technology and the Potential to Shape The Future of the Stem Cell Industry

Tue, 29 Sep 2009 13:06:00 0500

HAIFA, Israel-(Business Wire)-September 29, 2009 - Pluristem Therapeutics Inc. (NasdaqCM: PSTI...

The Cleveland Clinic Recognizes AxioMed Spine Corporation

Tue, 29 Sep 2009 13:05:00 0500

GARFIELD HEIGHTS, Ohio-(Business Wire)-September 29, 2009 - At the 6^th Annual Cleveland Clinic Innovator Awards dinner, AxioMed Spine Corporation (

Computable Genomix Announces Contest For Genomics Researchers

Tue, 29 Sep 2009 12:00:00 0500

MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool.

Publish or Perish will...

Vivakor Announces Former General Electric Healthcare Division Executive Joins Its Board of Directors

Tue, 29 Sep 2009 12:00:00 0500

CORALVILLE, Iowa-(Business Wire)-September 29, 2009 - Vivakor, Inc. (OTCBB: VIVK) today announced that John Gryga, former executive with General Electric’s Healthcare division and former Director of Operations for RadNet, has joined Vivakor’s Board of Directors. At RadNet, Mr. Gryga was...

SAIC-Frederick and Roche Enter into a Research Collaboration on Technology Advancements for Cancer Gene Sequencing

Tue, 29 Sep 2009 12:00:00 0500

MADISON, Wis.-(Business Wire)-September 29, 2009 - National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (NYSE: SAI), and Roche Applied Science, a division of Roche Diagnostics Corporation (SWX:RO) (SWX:ROG) (Pink...

Synta Pharmaceuticals Initiates Fourth Trial of STA-9090, a Novel Synthetic Small Molecule Hsp90 Inhibitor

Tue, 29 Sep 2009 12:00:00 0500

LEXINGTON, Mass.-(Business Wire)-September 29, 2009 - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical...

Aurora Breast MRI of Sarasota and Clear Channel Radio, Partner for “Change for Change” Fundraising Event

Tue, 29 Sep 2009 11:29:00 0500

SARASOTA, Fla.-(Business Wire)-September 29, 2009 - Aurora Breast MRI of Sarasota today announced it has partnered with Clear Channel Radio for a fundraising effort to benefit The Wellness Community of Southwest Florida. The fundraiser, titled “Change for Change,” will consist of a series...

Scarab Genomics Introduces ScarabXpress™ T7lac, a unique E. coli expression strain

Tue, 29 Sep 2009 11:27:00 0500

MADISON, Wis.-(Business Wire)-September 29, 2009 - ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome^® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene...

Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine

Tue, 29 Sep 2009 10:45:00 0500

BERKELEY, Calif.-(Business Wire)-September 29, 2009 - Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the initiation of a Phase 3 registration trial for HEPLISAV^TM hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a Phase 3...

Repros Therapeutics Inc. Provides Update on Proellex

Tue, 29 Sep 2009 10:30:00 0500

THE WOODLANDS, Texas-(Business Wire)-September 29, 2009 - Repros Therapeutics (NasdaqGM:RPRX) today announced that the Company has received further clarification from the Food and Drug Administration (FDA) on the Full Clinical Hold status of Proellex.

As announced in early August...

PPD Announces Third Quarter 2009 Earnings Release, Webcast and Conference Call

Tue, 29 Sep 2009 10:00:00 0500

WILMINGTON, N.C.-(Business Wire)-September 29, 2009 - PPD, Inc. (Nasdaq: PPDI) will release its third quarter 2009 financial results on Tuesday, October 27, 2009, after the market closes. The earnings release will be available on the PPD Web site at

Elan Corporation Plc Announces Cash Tender for Outstanding US$850M in Aggregate Principal Amount of 2011 Fixed Rate Notes

Tue, 29 Sep 2009 06:00:00 0500

DUBLIN, Ireland-(Business Wire)-September 29, 2009 - Elan Corporation, plc ("Elan") today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., are commencing a cash tender offer (the “Tender Offer”) for the outstanding US$850 million in...

Inc. Magazine Names InVivo Therapeutics CEO Frank Reynolds one of ‘America’s Most Innovative Entrepreneurs’

Mon, 28 Sep 2009 22:18:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Frank Reynolds, InVivo Therapeutics President and CEO, has been identified as one of ‘‘America’s most innovative entrepreneurs’ in the October 2009 issue of Inc. Magazine. In the article entitled “The New and Improved...

Flexible Stenting Solutions, Inc. Receives Conditional IDE Approval for FlexStent® Femoropopliteal Self Expanding Stent System

Mon, 28 Sep 2009 21:56:00 0500

EATONTOWN, N.J.-(Business Wire)-September 28, 2009 - Flexible Stenting Solutions Inc. (“FSS”), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its...

Astrotech Reports Financial Results for Fourth Quarter and Fiscal Year 2009 and Announces Exploration of Strategic Alternatives

Mon, 28 Sep 2009 20:20:00 0500

AUSTIN, Texas-(Business Wire)-September 28, 2009 - Astrotech Corporation (NASDAQ:ASTC) today announced financial results for its fourth quarter and fiscal year ended June 30, 2009.

“This reporting period commemorates our return to profitable earnings and the completion of the...

Maxygen Announces Management Changes

Mon, 28 Sep 2009 20:05:00 0500

REDWOOD CITY, Calif.-(Business Wire)-September 28, 2009 - Maxygen, Inc. (Nasdaq:MAXY) announced today that James Sulat, who currently serves as a director of the company, has been appointed to serve as Maxygen’s Chief Executive Officer, effective October 1, 2009. Mr. Sulat will replace...

Burzynski Research Institute Signs Research Agreement with the University of Alabama at Birmingham (UAB), Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility

Mon, 28 Sep 2009 19:14:00 0500

HOUSTON-(Business Wire)-September 28, 2009 - The Burzynski Research Institute, Inc. (BRI) today announced that it has signed a Research Agreement with the UAB Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility (BBSF) that will provide biostatistical and data...

Impax Laboratories to Present at the JMP Securities Healthcare Focus Conference

Mon, 28 Sep 2009 19:12:00 0500

HAYWARD, Calif.-(Business Wire)-September 28, 2009 - Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the JMP Securities Healthcare Focus Conference on Monday, October 5th, at 12:30 p.m. Eastern time. The conference will be held at The New...

The Tennessee Biotechnology Association (TBA) Announces New Board Members

Mon, 28 Sep 2009 18:58:00 0500

NASHVILLE, Tenn.-(Business Wire)-September 28, 2009 - The Tennessee Biotechnology Association:

Richard Magid, PhD is Vice President at the University of Tennessee Research Foundation (UTRF) at the UT Health Science Center (UTHSC), and manages the operations of the...

Top Bioscience Industry Leaders H. Tom Watkins and Tony Zook to Address Mid-Atlantic Bio Conference

Mon, 28 Sep 2009 17:14:00 0500

WASHINGTON-(Business Wire)-September 28, 2009 - H. Tom Watkins, president, CEO and director of Human Genome Sciences, Inc. (HGS) and Chair of The Maryland Life Sciences Advisory Board, and Tony Zook, AstraZeneca’s North America CEO and MedImmune’s President, will address the 2009 Mid-Atlantic...

Medtronic Continues Membership in the Dow Jones Sustainability Index and FTSE4Good Index

Mon, 28 Sep 2009 16:57:00 0500

MINNEAPOLIS-(Business Wire)-September 28, 2009 - Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a member company in the Dow Jones Sustainability Index (DJSI) for North America and the FTSE4Good...

Catalent Pharma Solutions Appoints New Sterile Segment President, Sales and Marketing Head

Mon, 28 Sep 2009 16:08:00 0500

SOMERSET, N.J.-(Business Wire)-September 28, 2009 - Catalent Pharma Solutions, Inc. announced today the appointment of Will Downie in a dual role as Group President, Sterile Technologies and Senior Vice President of Global Sales & Marketing, effective October 12, 2009. Mr. Downie will have...

Salix Pharmaceuticals to Present at JMP Securities Conference

Mon, 28 Sep 2009 15:15:00 0500

RALEIGH, N.C.-(Business Wire)-September 28, 2009 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the Fourth Annual JMP Securities Healthcare Focus Conference in New York, NY on Monday, October 5 at 11:30 a.m. ET.

Interested parties can...

DiscoveryBioMed, Inc. Awarded Phase 2 SBIR Grant by the NIH to Discover Hypertension and Cystic Fibrosis (CF) Drugs

Mon, 28 Sep 2009 15:00:00 0500

BIRMINGHAM, Ala.-(Business Wire)-September 28, 2009 - DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development...

Savvion and Patni Announce Strategic Partnership

Mon, 28 Sep 2009 14:00:00 0500

SANTA CLARA, Calif.-(Business Wire)-September 28, 2009 - Savvion® and Patni Life Sciences announced today a strategic...

German Consulate & State of Hessen Life Science Networking Event: “Innovative Solutions to Challenges in Life Science in Germany,” New York, Tuesday 10/6/2009

Mon, 28 Sep 2009 13:45:00 0500

NEW YORK-(Business Wire)-September 28, 2009 - German State of Hessen U.S. Office for Economic Development:

Biomagnetics Diagnostics Receives a Financing Commitment up to $1 Million to Speed Development of Malaria Testing Technology

Mon, 28 Sep 2009 13:30:00 0500

GENEVA-(Business Wire)-September 28, 2009 - Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced it has received a equity-based financing commitment up to $1 million...

BioForward Announces Moderator, Panelists for Summit’s Final Plenary Session

Mon, 28 Sep 2009 13:21:00 0500

MADISON, Wis.-(Business Wire)-September 28, 2009 - BioForward, the member-driven state association that is the voice of Wisconsin’s biotechnology industry, today announced moderator and panel participants for the closing plenary of the Biotechnology Vision Summit. The organization’s new...

iCAD to Present at America’s Growth Capital 6th Annual East Coast Emerging Growth Conference

Mon, 28 Sep 2009 13:00:00 0500

NASHUA, N.H.-(Business Wire)-September 28, 2009 - iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announced that Ken Ferry, President and Chief Executive Officer and Darlene...

Ligand and GlaxoSmithKline Collaboration Identifies New Compound

Mon, 28 Sep 2009 12:36:00 0500

SAN DIEGO-(Business Wire)-September 28, 2009 - Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that pursuant to an amendment to a March 2006 research agreement with GlaxoSmithKline (NYSE:GSK), GSK has agreed to accelerate the timing of a $500,000 payment to Ligand that...

Leading Japanese CRO Attains Highest Accreditation in Medidata Solutions’ ASPire to Win Partner Program

Mon, 28 Sep 2009 12:30:00 0500

NEW YORK & TOKYO-(Business Wire)-September 28, 2009 - Medidata Solutions (NASDAQ: MDSO), a leading global...

Celsion Corporation Announces $7.1 Million Registered Direct Offering

Mon, 28 Sep 2009 12:30:00 0500

COLUMBIA, Md.-(Business Wire)-September 28, 2009 - Celsion Corporation (the “Company”) (NASDAQ: CLSN), an innovative oncology drug development company dedicated to the development and commercialization of innovative oncology drugs, today announced that it has entered into definitive...

Lifeline Biotechnologies Completes the Updating of Pink Sheets

Mon, 28 Sep 2009 12:30:00 0500

RENO, Nev.-(Business Wire)-September 28, 2009 - Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO) today announced that it has completed the updating of the Company’s information on Pinks Sheets.

Jim Holmes, Lifeline’s CEO, said, “The ‘Stop Sign’ on our Company site at...

PolyMedix Receives U.S. Patent Protection for Licensed Computational Methods to Design Antimicrobial Polymers

Mon, 28 Sep 2009 12:26:00 0500

RADNOR, Pa.-(Business Wire)-September 28, 2009 - PolyMedix, Inc. (OTC BB: PYMX, PerkinElmer, Inc., a global leader focused on the...

CSL Biotherapies Reaches Agreement with Merck & Co. on Rights to Market and Distribute Afluria® in the U.S.

Mon, 28 Sep 2009 12:00:00 0500

KING OF PRUSSIA, Pa.-(Business Wire)-September 28, 2009 - CSL Biotherapies and its parent company...

Helicos Announces System Sale to Correlagen Diagnostics

Mon, 28 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis.

“We are very...

Halozyme Begins Clinical Trial to Compare Three Insulin Analogs and Provides Update on Ultrafast Insulin Program

Mon, 28 Sep 2009 11:29:00 0500

SAN DIEGO-(Business Wire)-September 28, 2009 - Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase...

Selcia Launches New Discovery Division with Powerful Fragment Screening Platform and Unveil Company Re-brand

Mon, 28 Sep 2009 11:05:00 0500

ONGAR, Essex, UK-(Business Wire)-September 28, 2009 - Selcia Ltd, a worldwide industry leading C-14 custom radiolabelling provider and drug discovery company this week launched their new Fragment Screening Platform and unveiled their new brand as part of ambitious international expansion plans...

Correlagen Announces Acquisition of System from Helicos BioSciences

Mon, 28 Sep 2009 11:00:00 0500

WALTHAM, Mass.-(Business Wire)-September 28, 2009 - Correlagen Diagnostics Inc., a leading provider of genetic testing for disease diagnosis, today announced the acquisition of a system from and a scientific collaboration with Helicos BioSciences Corporation (NASDAQ: HLCS).

“We...

Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies

Mon, 28 Sep 2009 11:00:00 0500

CARLSBAD, Calif. & HEIDELBERG, Germany-(Business Wire)-September 28, 2009 - febit holding GmbH

Covidien Announces Definitive Agreement to Acquire Aspect Medical Systems, Inc.

Mon, 28 Sep 2009 11:00:00 0500

DUBLIN, Ireland & NORWOOD, Mass.-(Business Wire)-September 28, 2009 - Covidien (NYSE: COV) and Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that Covidien has reached a definitive agreement to acquire Aspect, a global market leader in brain monitoring technology.

Inovio Biomedical to Present at Vaccine 3rd Global Congress

Mon, 28 Sep 2009 08:00:00 0500

SAN DIEGO-(Business Wire)-September 28, 2009 - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today it will make multiple presentations at the Vaccine 3^rd Global Congress being held in Singapore October 4^th

Vitrolife: Swemed Sense™ approved for sales in Australia

Mon, 28 Sep 2009 06:58:00 0500

STOCKHOLM, Sweden-(Business Wire)-September 28, 2009 - Regulatory News:

“Swemed Sense™, with its unique characteristics, is an important part of our existing product portfolio in Europe, and is now available even to our Australian customers, Says Vitrolife's Vice President of...

Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union

Fri, 25 Sep 2009 21:36:00 0500

WHITEHOUSE STATION, N.J.-(Business Wire)-September 25, 2009 - Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for...

Initial Clinical Results for New Omnisure™ Sling Released at the AUGS Annual Meeting

Fri, 25 Sep 2009 19:00:00 0500

RAYNHAM, Mass.-(Business Wire)-September 25, 2009 - Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest...

Accelr8 and Becton Dickinson Conclude Technical Development Project

Fri, 25 Sep 2009 17:14:00 0500

DENVER-(Business Wire)-September 25, 2009 - Accelr8 Technology Corporation (NYSE Amex: AXK) announced today that it has concluded a technical development project with Becton, Dickinson and Company (“BD”) (NYSE: BDX). Accelr8’s technology met formal testing requirements for...

Research and Markets: Top 10 Companies in the US Life Sciences Industry: IT Spending Predictor 2009 Out Now

Fri, 25 Sep 2009 14:26:00 0500

DUBLIN-(Business Wire)-September 25, 2009 - Research and Markets(

Affymax Secures $60 Million Issuer Managed Equity Facility with Azimuth Opportunity, Ltd.

Fri, 25 Sep 2009 13:15:00 0500

PALO ALTO, Calif.-(Business Wire)-September 25, 2009 - Affymax, Inc. (Nasdaq:AFFY) today announced that it has obtained an issuer managed equity facility under which it may sell up to $60 million of its registered common stock to Azimuth Opportunity, Ltd. Affymax is not obligated to utilize any...

Quintiles and Allergan Announce Co-Promotion for Sanctura XR®

Fri, 25 Sep 2009 13:00:00 0500

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 25, 2009 - Quintiles Transnational Corp. and Allergan, Inc. (NYSE: AGN) today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR^® (trospium chloride extended release capsules), an...

Covidien Announces Dividend Increase of 12.5%

Fri, 25 Sep 2009 13:00:00 0500

DUBLIN-(Business Wire)-September 25, 2009 - Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 12.5% increase in the quarterly dividend rate, from $0.16 per ordinary share to $0.18 per ordinary share.

“Given our good operational performance thus...

Idera Pharmaceuticals Presents Final Data from Phase 2 Clinical Trial of IMO-2055 Monotherapy in Renal Cell Carcinoma

Fri, 25 Sep 2009 13:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 25, 2009 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced the presentation of final data from a clinical trial evaluating IMO-2055, an agonist of Toll-like Receptor (TLR) 9, as monotherapy in patients with Renal Cell Carcinoma (RCC). The...

Advaxis Secures $5.0 Million Investment

Fri, 25 Sep 2009 12:30:00 0500

NORTH BRUNSWICK, N.J.-(Business Wire)-September 25, 2009 - Advaxis, Inc. (OTCBB: ADXS), has entered into a definitive agreement for a $5 million investment commitment (the “Investment”) with an investment fund (the “Investor”).

“This financing, combined with...

RXi Pharmaceuticals Obtains Direct Ownership of Previously Licensed RNAi Delivery Intellectual Property

Fri, 25 Sep 2009 12:30:00 0500

WORCESTER, Mass.-(Business Wire)-September 25, 2009 - RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct...

EnzymeRx Announces Its IND for Uricase-PEG 20 Becomes Effective

Fri, 25 Sep 2009 12:10:00 0500

PARAMUS, N.J.-(Business Wire)-September 25, 2009 - EnzymeRx, LLC (www.enzymerx.com), a...

Altor BioScience Awarded $3 MM SBIR Bridge Grant by NCI to Advance Clinical Trials for its Targeted Cancer Therapeutic ALT-801

Fri, 25 Sep 2009 12:00:00 0500

MIRAMAR, Fla.-(Business Wire)-September 25, 2009 - Altor BioScience Corporation announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase II Bridge Grant by the National Cancer Institute (NCI). The award of $3 MM over three years will help Altor further its...

Dyax Corp. to Present at the JMP Securities Healthcare Focus Conference

Fri, 25 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 25, 2009 - Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare...

NCKU Aquatic Animal Bio-Medicine R&D Team Awarded Gold Medal and Bronze Medal Again

Fri, 25 Sep 2009 11:28:00 0500

TAINAN, Taiwan-(Business Wire)-September 25, 2009 - The Aquatic Animal Bio-Medicine R&D Team (AABM Team) of National Cheng Kung University (NCKU) in Taiwan, led by Distinguished Prof. Huey-Lang Yang from Institute of Biotechnology, won two medals out of more than 100 teams in the national...

Allos Therapeutics’ FOLOTYN™ First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma

Fri, 25 Sep 2009 11:00:00 0500

WESTMINSTER, Colo.-(Business Wire)-September 25, 2009 - Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYN^TM (pralatrexate injection) for use as a single agent for the treatment...

Research and Markets: Modern Biotechnology: Connecting Innovations in Microbiology and Biochemistry to Engineering Fundamentals - Now Available

Fri, 25 Sep 2009 09:06:00 0500

DUBLIN-(Business Wire)-September 25, 2009 - Research and Markets (Advaxis, Inc. (OTCBB: ADXS), the live...

GeneWize Life Sciences, Inc., Approved As New Member of Direct Selling Association

Thu, 24 Sep 2009 18:15:00 0500

ORLANDO, Fla.-(Business Wire)-September 24, 2009 - GeneWize Life Sciences, Inc. (“GeneWize”), subsidiary of leading consumer genomics biotech company GeneLink, Inc. (OTCBB: GNLK.OB, “GeneLink”), today announced that the Direct Selling Association (“DSA”) has approved its...

Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting

Thu, 24 Sep 2009 17:54:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Vertex Pharmaceuticals Incorporated

HRC Fertility Offers Gene Security Parental Control for Embryonic Safety

Thu, 24 Sep 2009 16:55:00 0500

PASADENA, Calif.-(Business Wire)-September 24, 2009 - Over the past twenty-one years, HRC Fertility has...

Imprime PGG® Named a Top 10 Oncology Drug Candidate for Partnering

Thu, 24 Sep 2009 16:44:00 0500

EAGAN, Minn.-(Business Wire)-September 24, 2009 - Biothera, a privately held biotechnology company, announced today that its lead drug candidate, Imprime PGG^®, has been named one of the Top 10 Most Interesting Oncology Projects Available for Partnering by Windhover...

Inhibitex Regains Compliance with NASDAQ Listing Requirements

Thu, 24 Sep 2009 15:45:00 0500

ATLANTA-(Business Wire)-September 24, 2009 - Inhibitex, Inc. (Nasdaq: INHX) (the “Company”), a biopharmaceutical company focused on developing products to treat serious infectious diseases, announced today that it has received notice from The NASDAQ Stock Market ("Nasdaq") stating...

ProtoKinetix’ Advisory Boards Launch Major Commercial Initiatives for It’s AAGPs™

Thu, 24 Sep 2009 15:07:00 0500

VANCOUVER-(Business Wire)-September 24, 2009 - ProtoKinetix’ Business Advisory Board Chairman, Rear Admiral (Ret) Dr. Edward Martin, reported on progress implemented by the Corporate Advisory Boards. Attending the recent conference were Major General (Ret) Dr. John Parker and Vice Admiral (Ret...

TRADE NEWS: Agilent Technologies, Shanghai Institute of Biological Sciences and Chinese Academy of Sciences Open Center for Systems Biology

Thu, 24 Sep 2009 15:00:00 0500

SANTA CLARA, Calif. & SHANGHAI-(Business Wire)-September 24, 2009 - Agilent Technologies Inc. (NYSE:A) today announced the opening of the Shanghai Institute of Biological Sciences (SIBS)-Agilent Center for Systems Biology in Shanghai, China. The center will feature multiple technology...

Boston Scientific Founder John Abele Joins Nanobiosym Global Advisory Board

Thu, 24 Sep 2009 14:59:00 0500

BOSTON-(Business Wire)-September 24, 2009 - Nanobiosym® today announced that John Abele, Cofounder and former Co-Chairman of the multibillion-dollar global medical device company, Boston Scientific, has joined the Nanobiosym Global Advisory Board.

Over the past 30 years, Mr...

AmazingCharts.com Named Fastest-Growing Company In Rhode Island by Prestigious 2009 Inc. 500/5000 List

Thu, 24 Sep 2009 14:40:00 0500

SAUNDERSTOWN, R.I.-(Business Wire)-September 24, 2009 - AmazingCharts.com, Inc., a leading developer...

RegeneRx Biopharmaceuticals to Present Several Papers at Second International Symposium on Thymosins in Health and Disease

Thu, 24 Sep 2009 13:41:00 0500

BETHESDA, Md.-(Business Wire)-September 24, 2009 - REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) (Advanced BioHealing, Inc. (ABH), a...

Integrated Environmental Technologies, Ltd. Announces EcaFlo® Anolyte (Excelyte®) Effective Against Swine Flu (H1N1)

Thu, 24 Sep 2009 13:15:00 0500

LITTLE RIVER, S.C.-(Business Wire)-September 24, 2009 - Integrated Environmental Technologies, Ltd. (OTCBB: IEVM) announces the successful results of IET’s EcaFlo® Anolyte solution, marketed as Excelyte®, against Swine Influenza (H1N1). Specific testing performed by Microbiotest Labs of...

Health Discovery Corporation’s Dr. Stephen Barnhill Tells Participants at London Conference That Biomarkers Patented by His Company Promise to Revolutionize The Field of Molecular Diagnostics

Thu, 24 Sep 2009 13:15:00 0500

SAVANNAH, Ga.-(Business Wire)-September 24, 2009 - Dr. Stephen Barnhill, Chairman and CEO, Health Discovery Corporation (OTCBB: HDVY) (“HDC”), a molecular diagnostics company, spoke at the “Biomarkers in Clinical Trials” Conference taking place in London, September 23-24, 2009. The...

PHT Corporation Promotes Dwight Cooper to Vice President of Client Services

Thu, 24 Sep 2009 13:00:00 0500

BOSTON-(Business Wire)-September 24, 2009 - PHT Corporation, the leading provider of

Inovio Biomedical CEO Addresses MIT’s Emerging Technologies Conference

Thu, 24 Sep 2009 13:00:00 0500

SAN DIEGO-(Business Wire)-September 24, 2009 - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, Inovio’s CEO, presented keynote remarks at MIT’s Emerging Technologies Conference hosted by the...

Genzyme’s Campath Meets Primary Endpoint in Phase 3 Combination Therapy Trial for Chronic Lymphocytic Leukemia

Thu, 24 Sep 2009 12:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Genzyme Corporation (Nasdaq: GENZ) announced today...

IsoRay Inc. Announces Fiscal Year 2009 Results

Thu, 24 Sep 2009 12:30:00 0500

RICHLAND, Wash.-(Business Wire)-September 24, 2009 - IsoRay Inc. (AMEX:ISR), a medical isotope company focused on the treatment of lung cancer, head and neck tumors, prostate cancer and other malignant disease through use of its proprietary radioisotope technology, announces today its financial...

Liquidia Founder Receives Prestigious NIH Director’s Pioneer Award

Thu, 24 Sep 2009 12:15:00 0500

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 24, 2009 - Liquidia Technologies today announced its founder, Dr. Joseph DeSimone, has received the National Institutes of Health (NIH) Director’s Pioneer Award. Pioneer Awards are designed to support individual scientists of exceptional...

17th Annual BioPartnering Europe™ and BioPartnering China™ Presents Innovative and Informative Program, Addressing Latest Trends Affecting the Biotech Industry Today

Thu, 24 Sep 2009 12:11:00 0500

LONDON-(Business Wire)-September 24, 2009 - Technology Vision Group (TVG) is pleased to announce details of the program for the 17^th Annual BioPartnering Europe (BPE) and BioPartnering China (BPC) conference in London from 11-14 October 2009, providing four days of networking in...

Alkermes Announces Amylin and Lilly Will Present More than 20 Studies for Exenatide at EASD 2009

Thu, 24 Sep 2009 12:05:00 0500

SAN DIEGO & INDIANAPOLIS & CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) will unveil data from more than 20 studies at the 45th Annual Meeting of the European...

BSD Medical Corporation Files $50 Million Shelf Registration

Thu, 24 Sep 2009 12:00:00 0500

SALT LAKE CITY-(Business Wire)-September 24, 2009 - BSD Medical Corporation (NASDAQ:BSDM) (NNVC.OB) (the...

Pro-Pharmaceuticals to Present a Corporate Update at the Maxim Group Growth Conference

Thu, 24 Sep 2009 11:00:00 0500

NEWTON, Mass.-(Business Wire)-September 24, 2009 - Pro-Pharmaceuticals, Inc. (OTC: PRWP) today announced that Theodore Zucconi, Ph.D., Chief Executive Officer, and James Czirr, Chairman of the Board, Pro-Pharmaceuticals, Inc., are scheduled to present a corporate update at the Maxim...

Sepracor Announces Expiration of Hart-Scott-Rodino Waiting Period

Thu, 24 Sep 2009 11:00:00 0500

MARLBOROUGH, Mass.-(Business Wire)-September 24, 2009 - Sepracor Inc. ("Sepracor", NASDAQ: SEPR) today announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to the acquisition of Sepracor by Dainippon...

Teva Provides Update on Generic Evista® Litigation

Thu, 24 Sep 2009 10:30:00 0500

JERUSALEM-(Business Wire)-September 24, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA’s Orange Book for Eli Lilly’s Evista...

Life Technologies Initiates Suit Against Illumina Alleging Patent Infringement

Thu, 24 Sep 2009 01:22:00 0500

SAN DIEGO-(Business Wire)-September 24, 2009 - Illumina, Inc. (Nasdaq:ILMN) today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life...

Emergent Health Corp. (EMGE) Announces Pending Stock Split

Thu, 24 Sep 2009 00:27:00 0500

KING OF PRUSSIA, Pa.-(Business Wire)-September 24, 2009 - Emergent Health Corp. (Other OTC: EMGE) Emergent expects to review a stock split to increase shares for each share currently owned by existing shareholders. The final decision for the actual split ratio is expected to be made by October...

Results of ADAGIO Study with AZILECT® in Parkinson’s Disease Published in New England Journal of Medicine

Wed, 23 Sep 2009 21:01:00 0500

JERUSALEM-(Business Wire)-September 23, 2009 - Results from the ADAGIO trial, published online today in The New England Journal of Medicine, demonstrated that Parkinson’s disease patients receiving AZILECT^® (rasagiline) 1mg/day at the start of the study (early-start group...

Cambridge Heart Announces New Research and Development Initiative

Wed, 23 Sep 2009 20:35:00 0500

TEWKSBURY, Mass.-(Business Wire)-September 23, 2009 - Cambridge Heart, Inc. (OTCBB-CAMH) announced today that it intends to pursue research and development efforts on a new application derived from its core Microvolt T-Wave Alternans (MTWA) technology. The Company has gathered data, which...

FDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets

Wed, 23 Sep 2009 20:31:00 0500

CAMBRIDGE, Mass. & VANCOUVER-(Business Wire)-September 23, 2009 - CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) in a joint meeting of its Anesthetics and...

FDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets

Wed, 23 Sep 2009 20:18:00 0500

ST. LOUIS-(Business Wire)-September 23, 2009 - Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it presented information to members of a U.S. Food and Drug Administration (FDA) Advisory Committee on the New Drug Application and proposed Risk Evaluation...

Purohit Navigation Engages Users in Its New Web Site

Wed, 23 Sep 2009 19:07:00 0500

CHICAGO-(Business Wire)-September 23, 2009 - Not all healthcare agency Web sites are created equal, as Purohit Navigation’s redesigned Web site (

Perlegen Introduces BREVAGen™ Breast Cancer Risk Stratification Test

Wed, 23 Sep 2009 16:53:00 0500

MOUNTAIN VIEW, Calif.-(Business Wire)-September 23, 2009 - Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk and drug response, announced today that its BREVAGen™ breast cancer risk stratification test is now clinically available in select U.S...

BioVectra Announces Oncolix Inc. Signs Manufacturing and Investment Agreement

Wed, 23 Sep 2009 16:40:00 0500

CHARLOTTETOWN, PEI-(Business Wire)-September 23, 2009 - BioVectra, Inc., a cGMP manufacturing and development partner in Charlottetown, PEI, Canada, announces that it has reached an agreement with Oncolix Inc., a biopharmaceutical company based in Houston, Texas, to manufacture...

Cook Incorporated Wins Patent Infringement Appeal Filed By Edwards Lifesciences

Wed, 23 Sep 2009 15:39:00 0500

BLOOMINGTON, Ind.-(Business Wire)-September 23, 2009 - The United States Court of Appeals for the Federal Circuit today affirmed the previous ruling of the United States District Court for the Northern District of California that Cook Incorporated does not infringe on Edwards’ patents for...

LifeSensors, Inc. Obtains Worldwide, Exclusive License to High Affinity “Ubiquitin Traps”

Wed, 23 Sep 2009 15:16:00 0500

MALVERN, Pa.-(Business Wire)-September 23, 2009 - LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools...

European Commission Grants Conditional Marketing Authorization to Cayston® (Aztreonam Lysine) for the Treatment of Chronic Pulmonary Infections Due to Pseudomonas Aeruginosa in Patients with Cystic Fibrosis

Wed, 23 Sep 2009 15:06:00 0500

FOSTER CITY, Calif.-(Business Wire)-September 23, 2009 - Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the European Commission has granted conditional marketing authorization for Cayston^®75 mg powder and solvent for nebuliser solution (aztreonam lysine) for the suppressive...

Celladon's MYDICAR® and Small Molecule SERCA2a Studies in Acute and Chronic Heart Failure Selected as One of Windhover’s Top 10 Cardiovascular Programs to Watch

Wed, 23 Sep 2009 15:00:00 0500

SAN DIEGO-(Business Wire)-September 23, 2009 - Celladon Corporation today announced that its SERCA2a programs for the treatment of patients with acute and chronic heart failure have been chosen by Windhover and an independent expert panel as one of the top 10 most interesting cardiovascular...

ImThera Medical Completes Development of Targeted Hypoglossal Neurostimulation Treatment for OSA

Wed, 23 Sep 2009 14:53:00 0500

SAN DIEGO-(Business Wire)-September 23, 2009 - ImThera Medical, Inc. announced today that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA).

More than 800,000 patients in the US are annually diagnosed with...

Research and Markets: Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [Q3 2009 Edition]

Wed, 23 Sep 2009 14:37:00 0500

DUBLIN-(Business Wire)-September 23, 2009 - Research and Markets (MicroDose Therapeutx Inc. (formerly MicroDose...

MSGI Announces First Nanobeak Product -- Handheld Bloodless Diabetes Test

Wed, 23 Sep 2009 14:00:00 0500

NEW YORK-(Business Wire)-September 23, 2009 - MSGI Security Solutions Inc. (OTCBB: MSGI) today reported that the Company is launching its first product derived from NASA technology, a handheld test for Diabetes, which uses breath instead of blood.

Nanobeak Inc., an MSGI...

KIKA Clinical Solutions Announces Veracity™ 3.7, New Version of Advanced EDC Solution for Clinical Trial Management

Wed, 23 Sep 2009 13:35:00 0500

BOSTON & PARIS-(Business Wire)-September 23, 2009 - KIKA Clinical Solutions, the leading...

U.K. NICE Updates Clinical Guidelines to Support Use of Essure®

Wed, 23 Sep 2009 13:27:00 0500

MOUNTAIN VIEW, Calif.-(Business Wire)-September 23, 2009 - Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure procedure, the first proven non-incisional permanent birth control method available, today announced that the National Institute for Health and Clinical Excellence...

Abiomed Reports Results from Academic Medical Center’s Three-Year Follow-up of MACH II Trial

Wed, 23 Sep 2009 13:14:00 0500

DANVERS, Mass.-(Business Wire)-September 23, 2009 - Abiomed Inc. (NASDAQ: ABMD), a leading provider of

Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in Developing Countries

Wed, 23 Sep 2009 13:11:00 0500

NEW YORK-(Business Wire)-September 23, 2009 - Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world. This initiative is the first time a...

Bio-Computing a Major Focus of 22nd Annual SC Conference

Wed, 23 Sep 2009 13:00:00 0500

PORTLAND, Ore.-(Business Wire)-September 23, 2009 - SC09, the 22^nd annual supercomputing...

American Diversified Holdings Corporation to Enter Stem Storage Business

Wed, 23 Sep 2009 13:00:00 0500

DEL MAR, Calif.-(Business Wire)-September 23, 2009 - Ernest B. Remo, Chairman/CEO of American Diversified Holdings Corporation (Pink Sheets:ADHC), announced today that the company is currently in late stage negotiations with an established revenue producing company in the stem cell storage arena...

Advanced BioHealing Outlines Strategic Growth Plan

Wed, 23 Sep 2009 13:00:00 0500

WESTPORT, Conn.-(Business Wire)-September 23, 2009 - Advanced BioHealing, Inc.

Genzyme Provides Update on Cerezyme and Fabrazyme Supply

Wed, 23 Sep 2009 12:49:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 23, 2009 - Genzyme Corporation (NASDAQ: GENZ) today provided an update on its progress to restore supplies of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase beta) for patients worldwide and revised its 2009 revenue guidance for these...

Bio-Matrix Scientific Group and Therinject LLC Begin Development of Tumor Banking Facility in Conjunction with Cancer Therapeutic Vaccine

Wed, 23 Sep 2009 12:30:00 0500

SAN DIEGO-(Business Wire)-September 23, 2009 - Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) announced today that the Company and Therinject LLC have begun development of a tumor banking facility. Tumor banking will allow storage and ease of sourcing for tumor cells to be utilized in cancer...

Data Presented from Two Phase 3 ERBITUX® Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress

Wed, 23 Sep 2009 12:15:00 0500

BERLIN-(Business Wire)-September 23, 2009 - According to a recent retrospective analysis of the pivotal Phase 3 CRYSTAL study,

Philips and Bruker BioSpin Sign Memorandum of Understanding to Bring New Imaging Technology to the Preclinical Market